An in silico clinical trial is also known as a virtual clinical trial. It is a method used to develop drugs and medical devices using computer simulation, powered by artificial intelligence. This method allows testing the drug samples in virtual
BRAINTEASER takes part in the Brain Innovation Days 2022 The second edition of the Brain Innovation Days took place on 11-12 October 2022 in Brussels (Belgium) and featured BRAINTEASER as one of the exhibitors in the Innovation Hall. This year’s edition of the event
The use of in silico trials is expected to play an increasingly important role in the development and regulatory evaluation of new drugs and medical devices. One of the advantages that in silico approaches offer is the possibility to test
BRAINTEASER contribution to the DHSS 2022 The Digital Health Society Summit 4th edition, that took place virtually on October 4th and 5th 2022, has seen the contribution of BRAINTEASER in two relevant panel discussions: “How do you maximise the use of Health
The scope of this white paper is to clarify the different definitions of Digital Twin, Digital Patient, Virtual Patient and Synthetic Control Arm in the Pharma and MedTech fields. Please read more about it here: https://insilicotrials.com/white-papers/
An Interview with Nicola Ferro: Discovering The iDPP@CLEF Challenge 2022 For those of us who don’t know much about CLEF, can you tell us more about what it comprises and how the iDPP@CLEF Challenge plays a role? Of
Our new guest on In Silico Talks today is Giulia Russo, Assistant Professor at the University of Catania, Italy, and Chief Research Officer of MIMESIS, an academic spin-off of the same University focused on computational biomedicine. “By training I’m a
Let’s start 2022 with this very interesting interview with Francesco Pappalardo, professor of computer science and systems biomedicine at the University of Catania, adjunct professor at Boston University in USA and at Griffith University in Australia. He is a strong supporter of in silico methods in medicine. “I am a computer
Manuel Ottaviano has a M.Sc. Computer Science Engineering and a PhD in Bioengineering. He works as senior researcher in digital health and wellbeing at the University of Madrid UPM. He studies human factors implied in the design of digital technologies for health. He explores different
We met Oscar Camara, full professor of biomedical engineering at Universitat Pompeu Fabra, Barcelona. After studying telecommunication engineering in Barcelona, he went to Paris for a master and he started to work on medical image processing, which he loved as
Some months ago we created In Silico Talks, a series of video interviews with scientists , whose aim is to increase awareness around in silico medicine, and accelerate its uptake in the healthcare sector. These video interviews are becoming more
Our conversations on in silico methods in medicine are becoming more and more interesting. Christine Le Maitre, Professor of Cell Biology and Tissue Regeneration at Sheffield Hallam University, England, is the Head of the Tissue Engineering and Biomechanics Research Group